The malaria vaccine will be administered via intramuscular injection and delivered through the routine national immunization programmes. WHO recommendations and RTS,SRTS,S was developed by GSK and is the first malaria vaccine to have successfully completed a Phase III clinical trial. "The prospect of a malaria vaccine is great news. The injectable vaccine, RTS,S, was developed to protect young children from the most deadly form of malaria caused by Plasmodium falciparum. Brazzaville, 24 April 2017 - The World Health Organization Regional Office for Africa (WHO/AFRO) announced today that Ghana, Kenya, and Malawi will take part in a WHO-coordinated pilot implementation programme that will make the world's first malaria vaccine available in selected areas, beginning in 2018.
Why Kenyan kids will get malaria vaccine
At least 150,000 Kenyan children will receive the world's first-ever malaria Vaccine next year, latest reports show. "The prospect of a malaria vaccine is great news. The vaccine, also known as Mosquirix, was developed through a partnership between GlaxoSmithKline and the PATH Malaria Vaccine Initiative (MVI), with support from the Bill & Melinda Gates Foundation and from a network of African research centres. A vaccine would be a valuable addition to the measures currently taken to control malaria. In 2015, malaria killed an estimated 303,000 under-fives globally, including 292,000 in the African Region.collected by :Lucy William
No comments:
Post a Comment